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Background: Hepatitis B and C cause significant morbidity and mortality worldwide. Little is known about the
existence of hepatitis B and C among high risk groups of the Pakistani population. The present study was
conducted to determine the prevalence of Hepatitis B and C in high risk groups, their comparison and the possible
mode of acquisition by obtaining the history of exposure to known risk factors.
Methods: This cross sectional study was carried out in Karachi, from January 2007 to June 2008.
HBsAg and Anti HCV screening was carried out in blood samples collected from four vulnerable or at risk groups
which included injecting drug users (IDUs), prisoners, security personnel and health care workers (HCWs).
Demographic information was recorded and the possible mode of acquisition was assessed by detailed interview.
Logistic regression analysis was conducted using the STATA software.
Results: We screened 4202 subjects, of these, 681 individuals were reactive either with hepatitis B or C. One
hundred and thirty three (3.17%) were hepatitis B reactive and 548 (13.0%) were diagnosed with hepatitis C. After
adjusting for age, security personnel, prisoners and IV drug users were 5, 3 and 6 times more likely to be hepatitis B
reactive respectively as compared to the health care workers. IDUs were 46 times more likely to be hepatitis C
positive compared with health care workers.
Conclusion: The prevalence of hepatitis B and C was considerably higher in IDUs, prisoners and security personnel
compared to HCWs group. Hepatitis C is more prevalent than hepatitis B in all these risk groups. Prevalence of
hepatitis C increased with the increase in age. Use of unsterilized syringes, used syringes, body piercing and illicit
sexual relations were found to be important associated risk factors for higher prevalence of Hepatitis B and C in
these groups.
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Both hepatitis B and C are common infections affecting
masses and are the leading causes of chronic liver dis-
ease. Hepatitis B affects 350 to 400 million people
worldwide and accounts for 1 million deaths from cir-
rhosis, liver failure and hepatocellular carcinoma [1].
Hepatitis C affecting 130–170 million people worldwide,
is a leading cause of liver related deaths and most* Correspondence: k.shafique.1@research.gla.ac.uk
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reproduction in any medium, provided the orfrequent reason for liver transplantation [2,3]. About
two third of people suffering from hepatitis B and C are
residing in the developing countries [4].
Pakistan is in the intermediate zone of hepatitis B and
C prevalence areas. The prevalence is described as
around 4% and 6% respectively [5,6]. Higher prevalence
of Hepatitis B and C has been reported in certain areas
of Pakistan in small scale studies [7]. The reason for high
prevalence is explained by several factors including
transfusion of unscreened/improperly screened blood or
blood products [8], use of injections by unsterilized syr-
inges in general practice by quacks [9], nose prick or earl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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for shaving purposes [10,11]. Use of unsterilized syringes
among intravenous drug users is a significant risk factor of
Hepatitis B and C globally [12,13]. Pakistan is the country
with highest number of intramuscular injections injected
per person per year [14]. Horizontal transmission in chil-
dren appears to contribute more than vertical transmis-
sion for prevalence of chronic hepatitis B in this region.
Unprotected sex accounts for lesser number of cases than
those in developed countries.
Recently, Pakistan Medical and Research council has
conducted a community-based study showing a reduc-
tion in the prevalence rate of hepatitis B & C to 2.5%
and 4.9% respectively, in the general population [15].
This may be due to an increase in public awareness
regarding preventive strategies and inclusion of hepatitis
B vaccine in National immunization program since
2000. Higher prevalence however, have been reported in
certain high risk groups and in family members of hepa-
titis C patients [16,17]. Data of prevalence in high risk
groups is sparse and a comparison of different risk groups
is required to formulate national health policies and pre-
ventive strategies. Therefore the present study was con-
ducted to determine the prevalence of Hepatitis B and C
in high risk groups, their comparison and possible mode
of acquisition.
Methods
The study was conducted from January 2007 to December
2008 as part of an effort to control and prevent viral hepa-
titis in the province. Four vulnerable or at risk population
groups were identified for this cross-sectional study. These
included IV drug users, prisoners, security personnel and
healthcare workers. Health care workers were included in
high risk groups due to higher exposure to hepatitis
patients, routinely reported needle prick injuries and low
uptake of hepatitis vaccine. This group is of particular im-
portance because, infected health care workers can trans-
mit the infection to uninfected patients admitted to
hospital, which can further spread the disease in society.
We compiled a database of prisoners in Landhi Jail,
health care workers of the Civil Hospital Karachi, IDUs
registered by the Referral Laboratory of Sindh AIDS
Control Program and security personnel from a large
private company. A unique identification number was
assigned to all individuals in this database. A computer-
ized program was run to generate a random sample of
the individuals included in this database. All identified
individuals were then approached for a detailed inter-
view and blood sample collection. The response rate was
83% in this study with a total of 4202 individuals
included in this analysis.
We estimated the sample size to measure a 2% differ-
ence of hepatitis prevalence (assuming 4% prevalence)[5,6] between groups at 0.05 significance level using a
two-sided comparison and the power of 90%. Sample
size was computed for both the chi-squared test using
the Yates’ continuity correction and Fisher Exact test. A
sample of 3252 participants was the minimum number
required to be accrued in order to perform this survey.
Among HCWs, only staff from exposure-prone proce-
dures (EPP) was included in the study. These included inten-
sive care unit staff, surgeons, nursing staff, phlebotomists,
doctors, nurses and other paramedical staff providing direct
care to the patient. Demographic information of screened
people was recorded along with history of risk factors. A
team of laboratory workers was deputed to collect samples
from these groups. All samples were taken after obtaining
the informed consent. Consent was also obtained from the
institutional heads with assurance of confidentiality and
provision of treatment from the hepatitis control program.
The study protocol was reviewed and approved by an inde-
pendent ethics committee. Sample collection was carried out
at different sites for the groups as indicated. Five milliliter of
venous blood was collected in gel vaccutainer tubes (yellow
top) using aseptic technique. Blood samples were trans-
ported to the designated lab for further processing.
HBsAg and HCV Antibody tests were performed at
the central lab of the Civil Hospital Karachi (CHK) using
the CMEIA (Chemoluscent micro particle enzyme im-
munoassay) method on blood samples from HCW, pris-
oners and security personnel. Samples from IDUs were
tested at the Referral laboratory of Sindh AIDS Control
Program by ELISA Methods using Bio-Rad Monolisa
Antigen-antibody Coombo test kits.
Data were recorded and analyzed using the Stata Soft-
ware Version 11 (StataCorp, College Station, TX, USA).
We categorized the age using 10-year groups from 21–30,
31–40, and 41–50 years old. The means between groups
were compared using the independent sample t test and
analysis of variance (ANOVA) with bonferroni adjust-
ments for multiple comparisons was done. We explored
the association between age group, gender and risk group
by using the logistic regression model. Health-care worker
group was taken as a reference category when investigat-
ing the relationship between risk group and hepatitis B
and C. As this group may have prevalence of hepatitis B
and C approximate to the background population or may
be slightly higher than that. We constructed two different
models for hepatitis B and Hepatitis C. Age was found to
be significant on univariate analysis and was therefore
included in the final multivariate model to make appropri-
ate adjustments. The level of significance was set at 95%
(p value < 0.05).
Results
We screened 4202 subjects for hepatitis B and C, out of
these, 3637 were males and 565 were females. Female
Figure 1 Hepatitis B and C prevalence between different age
groups.
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health care workers group. The mean age of participants
was 41.07 ± 6.06. On average, females were significantly
(p < 0.001) younger than males (38.6 versus 41.4 years).
There was no significant difference of age between those
who were hepatitis B reactive (42.1 ± 6.09 years) com-
pared with non-reactive subjects (40.9 ± 5.97 years)
(Table 1).
A total of 681 participants were reactive either with
hepatitis B or C. One hundred and thirty three (3.17%)
were hepatitis B reactive and 548 (13.0%) were diag-
nosed with hepatitis C. The proportion of hepatitis B re-
active cases was fairly similar across different age
categories; however the frequency of hepatitis C reactive
cases was significantly higher among individuals of ages
between 41 to 50 years compared to the individuals of
age 21–30 years (p-value < 0.001) (Figure 1).
Mean age of prisoners and IDUs screened in this study
was significantly higher (p< 0.001) compared with health
care workers and security personnel. Difference observed
in the frequency of hepatitis C across different age cat-
egories was explored after adjusting the effect of the risk
group. Prevalence of hepatitis B and C differed signifi-
cantly between groups. Prevalence of hepatitis B and C
was lowest among HCWs (hepatitis B 1.0%, hepatitis C
2.9%), while prevalence of hepatitis B and C was highest
among IDUs (hepatitis B 5.7%, hepatitis C 68.3). Preva-
lence of hepatitis B was 1.1% higher among security
personnel compared with prisoners, while there was no
significant difference in prevalence of hepatitis C between
these two groups (Table 2). Individuals between the ages
of 41–50 years were 69% more likely to have reactive
hepatitis C as compared to those between the ages of 21–Table 1 Baseline characteristics of subjects screened for
Hepatitis B and C
Characteristics Number (n) %
Total participants (n) 4202 _








Health care workers 1051 25.00
Security personnel 457 10.88
Prisoners 2287 54.43
Intra venous drug users 407 9.6930 years after adjusting the group effect (OR 1.69, 95% CI
0.85–3.39).
In multivariate analysis there were no significant dif-
ferences observed in the likelihood of hepatitis B be-
tween different age categories and sex. However, after
adjusting for age, security personnel, prisoners and IDUs
were 5, 3 and 6 times more likely to be hepatitis B react-
ive respectively compared with the health care workers
group (Table 2).
In multivariate model (adjusting for sex and risk
group) for hepatitis C, age had no significant impact on
the likelihood of being reactive. Furthermore, after
adjusting for age, security personnel and prisoners had
significantly higher odds of being hepatitis C positive
(p = 0.003) (Table 2). Injecting drug users were 46 times
more likely to be hepatitis C positive compared to health
care workers after multivariate adjustments (Table 2).
Regarding risk factors, significantly high proportion of
prisoners and security personnel was found to had illicit
sexual relations i.e. 31% and 36% respectively, compared
with HCWs and IDUs (p-value 0.01). A history of blood
transfusion was also positive among a significant propor-
tion of participants between the risk groups. Injecting
drug users were significantly more likely to have a his-
tory of blood transfusion compared with other three risk
groups (p value 0.03). Interestingly, the use of heroin
injections was significantly higher among prisoners
(39%) compared with security personnel and health care
workers group (p-value 0.001), summary of other risk
factors have been provided in Table 3.
Discussion
Hepatitis B and C are endemic diseases in Pakistan and
carry high morbidity and mortality. This study was con-
ducted in four at risk or vulnerable groups and the
results indicate higher prevalence of both hepatitis B
and C among IDUs, prisoners and security personnel
compared with HCWs. Except the healthcare workers
group the prevalence of hepatitis B and C is much
higher in all other risk groups compared to general
population. Previous studies on HCWs in this region
Table 2 Association of hepatitis B and C infection with age and high risk group
Hepatitis B Hepatitis C
Characteristics Total Hepatitis B
reactive,n (%)
Adjusted odds ratios *
(95% Confidence interval)
p value Hepatitis C
reactive,n (%)




21–30 270 6 (2.2) 1 _ 10 (3.7) 1 _
31–40 1,609 48 (3.0) 0.95 (0.39–2.33) 0.91 201 (12.5) 1.67 (0.84–3.34) 0.13
41–50 2,323 79 (3.4) 1.03 (0.42–2.51) 0.94 337 (14.5) 1.69 (0.85–3.39) 0.12
Risk group
Health care workers 1,051 10 (1.0) 1 _ 30 (2.85) 1 _
Security personnel 457 21 (4.6) 5.03(2.35–10.78) 0.001 41 (8.97) 3.35 (2.06–5.45) <0.001
Prisoners 2,287 79 (3.5) 3.69 (1.87–7.24) 0.003 199 (8.7) 3.04 (2.04–4.53) <0.001
Intra venous drug users 407 23 (5.7) 6.16 (2.86–13.24) <0.001 278 (68.3) 46.60 (28.25–76.84) <0.001
* Odds ratio presented after mutual adjustments of all covariates mentioned in the table.
Table 3 Distribution of risk factors for hepatitis B and C among the high risk groups
High risk groups
Characteristics Health care workers Prisoners Security personnel IV drug users
N (%) N (%) N (%) N (%)
Total participants 1051 2287 457 407
Age, mean (s.d.)
Marital status 38.6 (6.8) 42.5 (5.1) 38.3 (6.8) 42.5 (4.9)
Umarried 210 (20) 1464 (64) 247 (54) 195 (48)
Married 841 (80) 823 (36) 210 (46) 212 (52)
Literacy level
Iliterate 74 (07) 1418 (62) 434 (95) 175 (43)
Literate 977 (93) 869 (38) 23 (05) 232 (57)
Current living arrangement
Home 1009 (96) 0 (0.0) 9 (02) 236 (58)
Streets 0 (0.0) 0 (0.0) 0 (0.0) 106 (26)
Shrine 0 (0.0) 0 (0.0) 0 (0.0) 20 (05)
Away from home 42 (04) 2287 (100) 448 (98)
Illicit sexual relation
No 1009 (96) 1578 (69) 292 (64) 330 (81)
Yes 42 (04) 709 (31) 165 (36) 77 (19)
Injection practices
Blood transfusion 21 (02) 91 (04) 9 (02) 33 (08)
Body piercing 74 (07) 480 (21) 55 (12) 12 (03)
Needle stick injury 231 (22) __ __ 102 (25)
Injection practices
heroin injections 0 (0.0) 892 (39) 9 (02) 269 (66)
injection more than 3 times/day 0 (0.0) 46 (02) 0 (0.0) 65 (16)
injection with used syringe 0 (0.0) 0 (0.0) 0 (0.0) 90 (22)
shared syringe/needle on last time 0 (0.0) 0 (0.0) 0 (0.0) 118 (29)
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population [18]. Our study however revealed a much
lower prevalence in the health care workers group,
which may be due to the better uptake of vaccination or
less exposure to the risk factors of hepatitis B and C.
Studies on HCWs from India have already shown a low
prevalence of hepatitis B and C infection due to vaccin-
ation for hepatitis B and better awareness regarding pre-
ventive strategies for hepatitis C [19].
High prevalence of hepatitis C and B in IV drug users is
already reported from all over the world including the In-
dian sub-continent [19,20]. Previous studies from Pakistan
on IDUs have also shown a high prevalence of hepatitis C,
B and HIV infections among IDUs [21,22]. Like previous
studies our study has also shown a significantly higher
prevalence of hepatitis C in this groupcompared to hepa-
titis B. We have also observed in our study a higher preva-
lence of hepatitis C among aging group (41–50) in all
categories compared to younger group (21–30) and simi-
lar results are shown in studies from India [19,23]. These
can be explained on the basis of multiple risk exposures of
aging groups including injections with unsterilized syr-
inges, blood transfusions and invasive procedures.
The prevalence of hepatitis C and B in this study is
much higher in IDUs and prisoners as compared to
HCWs. This might be explained by the increase in expos-
ure to unsterile syringes, sharing of syringes, illicit sexual
practices, body piercing and low literacy among IDUs and
prisoners. Both IDUs and prisoners are overlapping
groups as most prisoners are injecting drugs and also
involved in illicit sexual practices [23,24]. A high preva-
lence of hepatitis B and C has also been observed in secur-
ity personnel in our study. This section of the population
had not been studied in previous local studies but in this
study 98% of security personnel were living away from
their homes and two third of them had illicit sexual rela-
tions. There is a fair chance that these men may have
developed the disease due to illicit sexual behavior due to
their release from family restraints. This group of popula-
tion had significantly higher risk of contracting hepatitis B
and C as compared to the general population and required
to be involved in preventive programs. There is some evi-
dence, where, army recruits have shown a higher preva-
lence of hepatitis Bcompared withthe prevalence in the
general population [25]. A high prevalence of hepatitis B
and C among security personnel may also be explained on
the basis of health seeking behavior with the risk of getting
injection with unsterilized or reused syringes although our
data did not show evidence of injection practices in this
population group. Most of the security personnel in this
study belonged to rural areas. They prefer injections for
minor ailments and want to get rid of symptoms immedi-
ately to rejoin their duties. As chronic hepatitis B and C
are common causes of Hepatocellular Carcinoma inSoutheast Asia, effective hepatitis B vaccination programs,
prevention of hepatitis C by screening blood donors, uni-
versal precautions against blood contamination in health-
care settings and reducing hepatitis C transmission from
IDUs are important strategies to reduce hepatocellular
carcinoma incidence [26].
There are few limitations in our study which are worth
mentioning. We used cross sectional design for this study,
participants included were those who were asymptomatic
and were survivors of the disease, so there might be some
survivor bias as patients with more aggressive and end
stage disease might have died earlier and might not be
included. We could not study the hepatitis B vaccination
status in all the high risk groups and can only presume it
to be very low compared to health-care workers group
and this may be an additional reason for high prevalence
of hepatitis B in other groups. Also we have not studied
certain risk groups which has been included by other
researchers like professional blood donors [27], patients
receiving frequent transfusion of blood and blood pro-
ducts [16] and patients on haemodialysis [17]. A major
limitation of this study is the unequal sizes of risk groups;
this was mainly due to the difficulty in approaching IDUs
and security personnel for the screening program. Simi-
larly, females only took part from health care group while
we could not gain access to female groups in the rest of
the three risk groups. Although, our study showed a sig-
nificantly higher risk of hepatitis B and C among IDUs,
prisoners and security personnel,some groups had smaller
number of cases and confidence intervals were wide, these
may be chance findings which need further confirmation.
Also, future studies should attempt to include females of
high risk groups and other vulnerable groups need to be
examined like garbage collectors, immigrants especially
from Afghanistan and internally displaced people.
Our study highlights the importance of the control of
chronic hepatitis B and C in certain high risk groups as
these pools provide a trigger for the spread of disease in
the community. Vaccination for hepatitis B and prevent-
ive strategies for hepatitis C will not yield desirable
results unless it is controlled in these vulnerable groups
as a spillover of disease in the community will continue.
Conclusion
The present study showed a higher prevalence of hepatitis
C and B in IDUs and prisoners compared to HCWs
group. The prevalence of Hepatitis C is considerably
higher in these groups than hepatitis B. The prevalence of
hepatitis B and C is also significantly higher in security
personnel than HCWs group. Increase in age increases
the risk of hepatitis C in vulnerable groups. Useage of
unsterilized syringes, used syringes, body piercing and
illicit sexual relations are the primary reasons for higher
prevalence of hepatitis B and C in these groups.
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